US institution changes share price target for three big Danish drugmakers
![Photo: Jens Dresling](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13937941.ece/ALTERNATES/schema-16_9/doc7knouvbxg9c1d8v6fczf.jpg)
US-based private wealth manager Bernstein has taken stock of three large Danish drugmakers – Novo Nordisk, Lundbeck and Genmab – resulting in share price target changes for all three, Bloomberg News reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Cancer drug hope raises Genmab's spirits after legal defeat
For subscribers
Novo Nordisk target price increased by five institutions
For subscribers